Omalizumab Therapy for Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: A Synthesis of Published Evidence

被引：50
|
作者：
Tanou, Kalliopi [1 ,2 ]
Zintzaras, Elias [3 ,4 ]
Kaditis, Athanasios G. [1 ,2 ]
机构：
[1] Univ Athens, Sch Med, Dept Pediat 1, Pediat Pulmonol Unit, GR-11527 Athens, Greece
[2] Aghia Sophia Childrens Hosp, Athens, Greece
[3] Tufts Univ, Sch Med, Tufts Med Ctr, Ctr Clin Evidence Synth,Inst Clin Res & Hlth Poli, Boston, MA 02111 USA
[4] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece
来源：
PEDIATRIC PULMONOLOGY | 2014年 / 49卷 / 05期
关键词：
ABPA; A; fumigatus; anti-IgE; ANTI-IGE ANTIBODY; ABPA; CF;
D O I：
10.1002/ppul.22937
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis (CF) is treated with corticosteroids. Since elevated IgE is a cardinal abnormality, anti-IgE has been used sporadically as adjuvant treatment. In eight case reports, 13 children with CF and ABPA received anti-IgE resulting in improved FEV1, fewer respiratory symptoms and decreased corticosteroid use. Pediatr Pulmonol. 2014; 49:503-507. (c) 2013 Wiley Periodicals, Inc.
引用
收藏
页码：503 / 507
页数：5
相关论文
共 50 条
  • [1] Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Ashkenazi, Moshe
    Sity, Saray
    Sarouk, Ifat
    El Bar Aluma, Bat
    Dagan, Adi
    Bezalel, Yael
    Bentur, Lea
    De Boeck, Kris
    Efrati, Ori
    JOURNAL OF ASTHMA AND ALLERGY, 2018, 11 : 101 - 107
  • [2] Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients
    Nove-Josserand, Raphaele
    Grard, Soazic
    Auzou, Lila
    Reix, Philippe
    Murris-Espin, Marlene
    Bremont, Francois
    Mammar, Benyebka
    Mely, Laurent
    Hubert, Dominique
    Durieu, Isabelle
    Burgel, Pierre-Regis
    PEDIATRIC PULMONOLOGY, 2017, 52 (02) : 190 - 197
  • [3] Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature
    Li, Jian-Xiong
    Fan, Li-Chao
    Li, Man-Hui
    Cao, Wei-Jun
    Xu, Jin-Fu
    RESPIRATORY MEDICINE, 2017, 122 : 33 - 42
  • [4] Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis
    Emiralioglu, Nagehan
    Dogru, Deniz
    Tugcu, Gokcen Dilsa
    Yalcin, Ebru
    Kiper, Nural
    Ozcelik, Ugur
    ANNALS OF PHARMACOTHERAPY, 2016, 50 (03) : 188 - 193
  • [5] Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Lehmann, Sylvia
    Pfannenstiel, Claus
    Friedrichs, Frank
    Kroeger, Kristina
    Wagner, Norbert
    Tenbrock, Klaus
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2014, 8 (05) : 141 - 149
  • [6] Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
    Delgado Pecellin, Isabel
    Quintana Gallego, Esther
    Pedregal Solano, Celeste
    Calero Acuna, Carmen
    MEDICINA CLINICA, 2015, 144 (04): : 190 - 191
  • [7] Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis
    Thia, Lena P.
    Lynn, Ian M. Balfour
    PAEDIATRIC RESPIRATORY REVIEWS, 2009, 10 (01) : 37 - 42
  • [8] Allergic bronchopulmonary aspergillosis and omalizumab
    Tillie-Leblond, I.
    Germaud, P.
    Leroyer, C.
    Tetu, L.
    Girard, F.
    Devouassoux, G.
    Grignet, J. -P.
    Prudhomme, A.
    Dusser, D.
    Wallaert, B.
    ALLERGY, 2011, 66 (09) : 1254 - 1256
  • [9] Allergic bronchopulmonary aspergillosis and cystic fibrosis
    Levy, MB
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 : S579 - S583
  • [10] Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis
    Sunman, Birce
    Ademhan Tural, Dilber
    Ozsezen, Beste
    Emiralioglu, Nagehan
    Yalcin, Ebru
    Ozcelik, Ugur
    FRONTIERS IN PEDIATRICS, 2020, 8
12345